Loading
Latest filing published 13 Dec 2022 for Bellerophon Therapeutics, Inc.. Read the official filing
No signal scores available.
Our data holds just one disclosure by Parag Suresh Shah, dated 13 December 2022, reporting an option exercise in Bellerophon Therapeutics, Inc. Further filings will be added here. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration